BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9510184)

  • 1. Peptide selection by an MHC H-2Kb class I molecule devoid of the central anchor ("C") pocket.
    Molano A; Erdjument-Bromage H; Fremont DH; Messaoudi I; Tempst P; Nikolić-Zugić J
    J Immunol; 1998 Mar; 160(6):2815-23. PubMed ID: 9510184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of longer peptides to the H-2Kb heterodimer is restricted to peptides extended at their C terminus: refinement of the inherent MHC class I peptide binding criteria.
    Hörig H; Young AC; Papadopoulos NJ; DiLorenzo TP; Nathenson SG
    J Immunol; 1999 Oct; 163(8):4434-41. PubMed ID: 10510385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide binding to MHC class I is determined by individual pockets in the binding groove.
    Johansen TE; McCullough K; Catipovic B; Su XM; Amzel M; Schneck JP
    Scand J Immunol; 1997 Aug; 46(2):137-46. PubMed ID: 9583994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure in expression of structurally altered (CYS164-->TYR) H-2Kb molecules is mitigated with high affinity peptide-ligand.
    Tatake RJ; Zeff RA
    Transplantation; 1995 May; 59(9):1343-9. PubMed ID: 7762072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of peptides lacking consensus anchor residue alters H-2Ld serologic recognition.
    Solheim JC; Carreno BM; Smith JD; Gorka J; Myers NB; Wen Z; Martinko JM; Lee DR; Hansen TH
    J Immunol; 1993 Nov; 151(10):5387-97. PubMed ID: 7693810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes at the floor of the peptide-binding groove induce a strong preference for proline at position 3 of the bound peptide: molecular dynamics simulations of HLA-A*0217.
    Toh H; Savoie CJ; Kamikawaji N; Muta S; Sasazuki T; Kuhara S
    Biopolymers; 2000 Oct; 54(5):318-27. PubMed ID: 10935972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A molecular basis for how a single TCR interfaces multiple ligands.
    Boesteanu A; Brehm M; Mylin LM; Christianson GJ; Tevethia SS; Roopenian DC; Joyce S
    J Immunol; 1998 Nov; 161(9):4719-27. PubMed ID: 9794402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino acid changes in the peptide binding site have structural consequences at the surface of class I glycoproteins.
    Pease LR; Horton RM; Pullen JK; Hunt HD; Yun TJ; Rohren EM; Prescott JL; Jobe SM; Allen KS
    J Immunol; 1993 Apr; 150(8 Pt 1):3375-81. PubMed ID: 7682238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MHC class I-restricted immune response to HIV-gag in BALB/c mice selects a single epitope that does not have a predictable MHC-binding motif and binds to Kd through interactions between a glutamine at P3 and pocket D.
    Mata M; Travers PJ; Liu Q; Frankel FR; Paterson Y
    J Immunol; 1998 Sep; 161(6):2985-93. PubMed ID: 9743362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Carboxy Terminus of the Ligand Peptide Determines the Stability of the MHC Class I Molecule H-2Kb: A Combined Molecular Dynamics and Experimental Study.
    Abualrous ET; Saini SK; Ramnarayan VR; Ilca FT; Zacharias M; Springer S
    PLoS One; 2015; 10(8):e0135421. PubMed ID: 26270965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-dimensional structure of H-2Dd complexed with an immunodominant peptide from human immunodeficiency virus envelope glycoprotein 120.
    Li H; Natarajan K; Malchiodi EL; Margulies DH; Mariuzza RA
    J Mol Biol; 1998; 283(1):179-91. PubMed ID: 9761682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prediction and binding of a mutant p53 peptide to MHC class I molecule].
    Huang L; Luo L; Li M
    Zhonghua Zhong Liu Za Zhi; 1997 Jul; 19(4):249-52. PubMed ID: 11038750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of an H-2Kb-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove.
    Fremont DH; Stura EA; Matsumura M; Peterson PA; Wilson IA
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2479-83. PubMed ID: 7708669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of anchor residue modifications on the stability of major histocompatibility complex class I-peptide interactions.
    Neefjes JJ; Dierx J; Ploegh HL
    Eur J Immunol; 1993 Apr; 23(4):840-5. PubMed ID: 8384560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An approach to the study of structure-function relationships of MHC class I molecules: isolation and serologic characterization of H-2Kb somatic cell variants.
    Geier SS; Zeff RA; McGovern DM; Rajan TV; Nathenson SG
    J Immunol; 1986 Aug; 137(4):1239-43. PubMed ID: 2426357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relative energetic contributions of dominant P1 pocket versus hydrogen bonding interactions to peptide:class II stability: implications for the mechanism of DM function.
    Bandyopadhyay A; Arneson L; Beeson C; Sant AJ
    Mol Immunol; 2008 Mar; 45(5):1248-57. PubMed ID: 17980431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural principles that govern the peptide-binding motifs of class I MHC molecules.
    Zhang C; Anderson A; DeLisi C
    J Mol Biol; 1998 Sep; 281(5):929-47. PubMed ID: 9719645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition of an MHC class I-restricted antigenic peptide can be modulated by para-substitution of its buried tyrosine residues in a TCR-specific manner.
    Saito NG; Chang HC; Paterson Y
    J Immunol; 1999 May; 162(10):5998-6008. PubMed ID: 10229839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide-binding motif prediction by using phage display library for SasaUBA*0301, a resistance haplotype of MHC class I molecule from Atlantic Salmon (Salmo salar).
    Zhao H; Hermsen T; Stet RJ; Skjødt K; Savelkoul HF
    Mol Immunol; 2008 Mar; 45(6):1658-64. PubMed ID: 18206244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mode of ligand recognition by two peptide:MHC class I-specific monoclonal antibodies.
    Messaoudi I; LeMaoult J; Nikolić-Zugić J
    J Immunol; 1999 Sep; 163(6):3286-94. PubMed ID: 10477598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.